YMI Health Launches Breakthrough A.I.-driven Predictive Analysis Tool, Empowering People With a Clearer Picture of Their Own Mental Health
In-depth, Private and Expert-Developed System Gives the Public Better Access to Mental Health Resources
CALGARY, AB, Dec. 7, 2022 /CNW/ - YMI Health, a division of nDatalyze Corp., is pleased to announce the launch of YMI, a comprehensive new breakthrough mental health tool in its mission to help the public gain a better understanding of their mental health, and in the process, help alleviate the massive strain currently placed on mental health system resources.
Created by doctors, psychotherapists, data scientists and other experts, YMI was designed to address one of the biggest problems currently facing the mental health system: Access to clinical resources. The predictive survey generates a population normal baseline and uses supervised artificial intelligence to generate insights on the degree of how individuals' genetic expressions, childhood and life experiences affect their mental wellbeing. It then provides resources to connect with qualified experts for treatment.
"Long before the pandemic brought mental health to the fore, the internet had spawned a self-diagnosis movement that has propelled skyrocketing demand for mental health services leading to an overload of the mental health system," says James Durward, President of nDatalyze Corp. "Traditional diagnostic processes that rely on short subjective self-reporting questionnaires that, whether administered by psychotherapists or individuals, can be wrong greater than 60% of the time. The process often sees people waiting months and spending thousands just to get through the diagnostic process that should happen before treatment.
"An unintended consequence of this," Durward adds, "is that many low urgency cases have clogged the system and pre-empted high probability cases where help is more urgently needed. Exacerbating the problem is that misdiagnosis is often followed by misprescription of drugs that can result in adverse side-effects or even new mental conditions. YMI is designed to address these factors by providing an advanced digital, objective, quantifiable tool for predictive mental health screening to the public and psychotherapists alike."
YMI's position is supported by Dr. Keith Courtney, a Board-Certified Psychiatrist who consulted on YMI's scoring algorithms. "I also think YMI aids in triage," Dr. Courtney says. "And that's the problem with the [mental health] system." An interview with Dr. Courtney can be seen here.
YMI uses a holistic, evidence-based, objective data from whole life experiences to predict why you are who you are, and applies this knowledge towards a fuller understanding of how to improve your mental wellbeing. After registering at YMIHealth.ca, users are given access to a private, in-depth survey that applies artificial intelligence using a person's genetic expressions, childhood environment, habits, phobias, lived experiences and lifestyle. Upon completion of the survey, YMI generates a personalized graphic report predicting a person's predisposition for seven mental conditions including anxiety, depression, post-traumatic stress disorder, obsessive compulsive disorder, alcoholism, and personality disorders both current and forward in time. The downloadable report may be used for reference as the user considers changes to their lifestyle that may help improve their mental wellbeing and mental health journey. The service also helps connect users with licensed therapists who are prepared to help with next steps, providing further clarity and treatment as required.
"The YMI digital tool combines a whole-life approach with artificial intelligence to establish mental health normative data. These norms allow fast, unbiased and consistent prediction of the underlying causes of mental conditions, their severity and how the severity might change with age. It also predicts the changes needed to improve one's mental health functioning." says Dr. Carol Malec, PhD, Psychologist, another of YMI's consultants. Dr. Malec adds: "Positive change requires an informed, comparative starting point and that's what YMI provides. I am quite excited about its potential to change the way we practice and provide mental health services."
As part of the launch, YMI is offered at a reduced introductory price of $99.00, including one user profile, five survey credits and a full year's access to reports.
YMI, a division of nDatalyze Corp., provides a predictive artificial intelligence-based mental condition analysis tool designed to significantly decrease the extremely high mental health misdiagnosis rates and the misprescriptions that follow. YMI applies advanced supervision algorithms to the Company's proprietary dataset consisting of extensive biometric and EEG data. YMI predicts and graphically displays the probability of seven common mental illnesses for the current time and into the future. YMI also allows the user to identify primary causes. YMI is patent pending.
nDatalyze Corp. generates technology-based, health-related solutions. The YMI division is developing a machine-learning based, online consumer mental health application with its database licensing division focusing on providing a specialized health-related Reference Database to application developers and researchers. YMI is based on the Corporation's proprietary Reference Database consisting of more than 1200 biometric records complete with associated electroencephalogram ("EEG") data.
Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. This news release does not constitute an offer to sell or a solicitation of an offer to sell any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.
The information in this news release includes certain information and statements about management's view of future events, expectations, plans and prospects that constitute forward looking statements. These statements are based upon assumptions that are subject to significant risks and uncertainties. Because of these risks and uncertainties and as a result of a variety of factors, the actual results, expectations, achievements or performance may differ materially from those anticipated and indicated by these forward looking statements. Any number of factors could cause actual results to differ materially from these forward-looking statements as well as future results. Although the Corporation believes that the expectations reflected in forward looking statements are reasonable, it can give no assurances that the expectations of any forward-looking statements will prove to be correct. Except as required by law, the Corporation disclaims any intention and assumes no obligation to update or revise any forward-looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting such forward looking statements or otherwise.
SOURCE YMI Health
Media Contact: [email protected], 416-585-2090
Share this article